"It really has changed the way I manage our patients"

Patients with CRS with nasal polyps may have to endure repeated use of steroids and revision sinus surgeries.1,2 Learn from Joseph Han, MD, FARS, FAAAAI on how DUPIXENT “really has changed the way I manage our patients.”

DUPIXENT can decrease the amount of revision polyp surgeries and prevent polyps from coming back, while continuing to avoid the need for steroids.3

    1. Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74(12):2312-2319. doi:10.1111/all.13875
    2. Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(suppl S29):1-464.doi:10.4193/Rhin20.600
    3. DUPIXENT Summary of Product Characteristics, 2022.

MAT-BH-2201031/V1/FEB2023